| 摘要 |
<p>This invention relates to novel 1, 2-benzisoxazol-3-yl compounds of formula (I), their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an antagonist of both dopamine and serotonin receptors. (I), wherein:at least one R group (i.e., R<SUP>1a</SUP>, R<SUP>1b</SUP>, R<SUP>2</SUP>, R<SUP>3a</SUP>, and R<SUP>3b</SUP>) comprises a deuterium atom.</p> |
